SEC Form 4 · accession 0001645627-17-000023
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 24, 2017
Accepted (ET)
Mar 27, 2017 · 2:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.051 | A | 19,895,849 | D | |
| Common Stock | Mar 24, 2017 | P | 2,000 | $0.0515 | A | 19,897,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.053 | A | 19,898,849 | D | |
| Common Stock | Mar 27, 2017 | P | 2,000 | $0.0489 | A | 19,900,849 | D | |
| Common Stock | Mar 27, 2017 | P | 2,000 | $0.048 | A | 19,902,849 | D | |
| Common Stock | Mar 27, 2017 | P | 1,000 | $0.0479 | A | 19,903,849 | D |
Table II — derivative securities
No Table II lines on this filing.